BioCentury | May 21, 2012
Strategy

Remembrance: The Titan who changed our lives

...Rathmann when he recruited me to join him at Hyseq, which we later transformed into Nuvelo...
BioCentury | Feb 8, 2010
Company News

Onyx management update

...Hired: Ted Love as EVP and head of R&D, formerly chairman, president and CEO of Nuvelo Inc....
BioCentury | Feb 2, 2010
Company News

Onyx names Love head of R&D

...Love as EVP and head of R&D. Love was previously chairman, president and CEO of Nuvelo Inc....
BioCentury | Jun 1, 2009
Company News

Arca biopharma cardiovascular news

...company had a 12-month operating loss of $33.3 million. Arca completed a reverse merger with Nuvelo Inc....
BioCentury | Feb 2, 2009
Company News

Arca biopharma, Nuvelo deal

...previously announced reverse merger (see BioCentury, Sept. 29, 2008). Arca biopharma Inc. , Broomfield, Colo. Nuvelo Inc....
BioCentury | Dec 22, 2008
Clinical News

NU206: Phase I data

...NU206 up to 0.2 mg/kg had a favorable safety profile with no serious adverse events. Nuvelo Inc....
BioCentury | Sep 29, 2008
Product Development

BEST foot forward

...able to use the $50 million it will pick up in a reverse merger with Nuvelo Inc....
...sights set on FDA approval, Arca announced last week that it will reverse merge with Nuvelo...
...not know how big such studies might be and thus how much they might cost. Nuvelo's...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

...a formal co-development agreement in which it would share costs and profits (see B5) . Nuvelo...
BioCentury | Sep 29, 2008
Company News

Arca biopharma, Nuvelo deal

...Arca agreed to reverse merge. Arca shareholders will own 67% of the combined company, and Nuvelo...
...MI) in patients with symptomatic chronic heart failure. The PDUFA date is May 31, 2009. Nuvelo's...
...fund operations at least through 2009. At June 30, Nuvelo had $70 million in cash. Nuvelo...
BioCentury | Sep 26, 2008
Top Story

Nuvelo and Arca to reverse merge

...Colo.) agreed to reverse merge. Arca shareholders will own 67% of the combined company, and Nuvelo...
...MI) in patients with symptomatic chronic heart failure. The PDUFA date is May 31, 2009. Nuvelo's...
...II testing in coronary artery bypass graft ( CABG ) surgery in 4Q08 or 1Q09. Nuvelo...
Items per page:
1 - 10 of 223
BioCentury | May 21, 2012
Strategy

Remembrance: The Titan who changed our lives

...Rathmann when he recruited me to join him at Hyseq, which we later transformed into Nuvelo...
BioCentury | Feb 8, 2010
Company News

Onyx management update

...Hired: Ted Love as EVP and head of R&D, formerly chairman, president and CEO of Nuvelo Inc....
BioCentury | Feb 2, 2010
Company News

Onyx names Love head of R&D

...Love as EVP and head of R&D. Love was previously chairman, president and CEO of Nuvelo Inc....
BioCentury | Jun 1, 2009
Company News

Arca biopharma cardiovascular news

...company had a 12-month operating loss of $33.3 million. Arca completed a reverse merger with Nuvelo Inc....
BioCentury | Feb 2, 2009
Company News

Arca biopharma, Nuvelo deal

...previously announced reverse merger (see BioCentury, Sept. 29, 2008). Arca biopharma Inc. , Broomfield, Colo. Nuvelo Inc....
BioCentury | Dec 22, 2008
Clinical News

NU206: Phase I data

...NU206 up to 0.2 mg/kg had a favorable safety profile with no serious adverse events. Nuvelo Inc....
BioCentury | Sep 29, 2008
Product Development

BEST foot forward

...able to use the $50 million it will pick up in a reverse merger with Nuvelo Inc....
...sights set on FDA approval, Arca announced last week that it will reverse merge with Nuvelo...
...not know how big such studies might be and thus how much they might cost. Nuvelo's...
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

...a formal co-development agreement in which it would share costs and profits (see B5) . Nuvelo...
BioCentury | Sep 29, 2008
Company News

Arca biopharma, Nuvelo deal

...Arca agreed to reverse merge. Arca shareholders will own 67% of the combined company, and Nuvelo...
...MI) in patients with symptomatic chronic heart failure. The PDUFA date is May 31, 2009. Nuvelo's...
...fund operations at least through 2009. At June 30, Nuvelo had $70 million in cash. Nuvelo...
BioCentury | Sep 26, 2008
Top Story

Nuvelo and Arca to reverse merge

...Colo.) agreed to reverse merge. Arca shareholders will own 67% of the combined company, and Nuvelo...
...MI) in patients with symptomatic chronic heart failure. The PDUFA date is May 31, 2009. Nuvelo's...
...II testing in coronary artery bypass graft ( CABG ) surgery in 4Q08 or 1Q09. Nuvelo...
Items per page:
1 - 10 of 223